OPK – opko health, inc. (US:NASDAQ)
Stock Stats
News
OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication [Yahoo! Finance]
Fortune [Fortune]
OPKO Health, Inc. (NASDAQ: OPK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders
Form SCHEDULE 13D/A OPKO HEALTH, INC. Filed by: FROST PHILLIP MD ET AL
Form SCHEDULE 13D/A OPKO HEALTH, INC. Filed by: HSIAO JANE PH D
Form 4 OPKO HEALTH, INC. For: Apr 01 Filed by: FROST PHILLIP MD ET AL
Form 8-K OPKO HEALTH, INC. For: Mar 28
Form 4 OPKO HEALTH, INC. For: Mar 28 Filed by: FROST PHILLIP MD ET AL
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.